An activatable DNA nanodevice for correlated imaging of apoptosis-related dual proteins

Zhixiang Li1,2, Xueyan Feng2, Wenping Hu1

  • 1Tianjin Key Laboratory of Molecular Optoelectronic Sciences, Department of Chemistry, School of Science, Tianjin 300072, China.

Nanoscale
|April 13, 2022
PubMed

Insights

Researchers developed a novel DNA nanodevice for real-time imaging of apoptosis. This tool can simultaneously detect dual apoptosis biomarkers, aiding disease monitoring and drug efficacy evaluation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nanotechnology

Background:

  • Apoptosis is crucial for multicellular life and disease progression.
  • Monitoring apoptosis biomarkers aids disease assessment and therapeutic evaluation.
  • Current imaging probes lack the ability to detect multiple biomarkers simultaneously during drug-induced apoptosis.

Purpose of the Study:

  • To design a novel DNA nanodevice for real-time, simultaneous imaging of apoptosis-related dual proteins.
  • To enable spatially selective detection of key apoptosis markers in living cells.
  • To establish a tool for monitoring apoptosis and evaluating drug efficacy.

Main Methods:

  • Designed an activatable DNA nanodevice.
  • Utilized specific recognition properties for target biomarkers.
  • Demonstrated real-time imaging in living cells.

Main Results:

  • The DNA nanodevice successfully imaged apoptosis-related dual proteins in real time.
  • Achieved spatially selective detection of cytochrome c and apurinic/apyrimidinic endonuclease 1.
  • Showcased the nanodevice's ability to monitor apoptosis and assess drug efficacy.

Conclusions:

  • The developed DNA nanodevice enables sensitive, simultaneous detection of apoptosis biomarkers.
  • This probe facilitates real-time monitoring of apoptosis and evaluation of drug effects.
  • The nanodevice holds potential for studying apoptosis mechanisms and screening drugs.

Related Concept Videos